US-based Tome Biosciences to retrench 131 employees
Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Tome Biosciences, a US company engaged in gene editing, will lay off 131 employees as it plans to reduce costs, according to a.
HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US.
HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory.
HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.
HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.
HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for.